2026 NPPES data Addiction (Substance Use Disorder) Registered Nurse NPI 1407203482
Verify on CMS →

Akwasi Agyemang

Addiction (Substance Use Disorder) Registered Nurse in Columbus, Ohio.

This profile is drawn from the federal National Provider Identifier Registry (CMS NPPES), which lists more than 7 million U.S. healthcare providers - including 2,788 in Addiction (Substance Use Disorder) Registered Nurse, and covers specialty classification, practice address, and Medicare Part D prescribing data when reported. According to CMS, every field reflects the provider's official federal registration, see our methodology.

Federal data, no proprietary rating. We show these CMS records as-is - no composite score, no star rating, no editorial opinion layered on top.
Prescribing volume
1K
Medicare Part D claims · 75 beneficiaries · Addiction (Substance Use Disorder) Registered Nurse avg: 955
Generic prescribing
87%
generic claims · 12% brand-name · higher generic rates reduce patient out-of-pocket costs
Industry payments
$110.69
1 payments · CMS Open Payments (Sunshine Act)
Compiled from official public sources by the PlainDoctor editorial team.

What the federal data shows

Akwasi Agyemang filed 1,269 Medicare Part D claims in 2023 as a Addiction (Substance Use Disorder) Registered Nurse in Columbus, Ohio, prescribing 87% generic.

1K
Part D claims, 2023
87%
generic prescribing
$110.69
industry payments (Sunshine Act)

Every figure on this page comes straight from federal CMS records (NPPES, Medicare Part D, MIPS, Open Payments) - no proprietary rating or editorial opinion is applied.

Akwasi Agyemang's Medicare Part D volume vs every U.S. prescriber

Total Medicare Part D claims, 2023, across all CMS prescribers nationally

1,269 Top 22% higher than 78% of 1,370,886 prescribers

0–200: 670,926 prescribers (49%). Below this entry. 200–400: 182,923 prescribers (13%). Below this entry. 400–600: 90,619 prescribers (7%). Below this entry. 600–800: 56,224 prescribers (4%). Below this entry. 800–1,000: 40,919 prescribers (3%). Below this entry. 1,000–1,200: 31,827 prescribers (2%). Below this entry. 1,200–1,400: 26,224 prescribers (2%). This entry sits in this band. 1,400–1,600: 21,710 prescribers (2%). Above this entry. 1,600–1,800: 19,072 prescribers (1%). Above this entry. 1,800–2,000: 16,451 prescribers (1%). Above this entry. 2K+: 213,991 prescribers (16%). Above this entry. This provider 0 2K+ every Part D prescriber (claims/yr), bucketed by value

Each bar is a band; taller bars hold more prescribers. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count, share, and where it sits relative to this entry.

Source CMS Medicare Part D Prescriber Public Use File · 2023

What does the federal data show about Akwasi Agyemang?

Quality data not reported

NPI registry status

Active

Issued 05/19/2016

NPI 1407203482

Primary specialty

Addiction (Substance Use Disorder) Registered Nurse

Niche

2,788 US NPIs in this specialty

Medicare Part D claims

1,269 33% vs specialty avg

2023 prescription claims

Specialty avg: 955

Specialty distribution in Ohio

How Addiction (Substance Use Disorder) Registered Nurse compares to other specialties among Ohio providers

Ohio providers
Case Manager/Care Coordinator - 10.9%Case Manager/Care Coordinator10.9%Student in an Organized Health Care Education/Training Program - 4.7%Student in an Organized Health Care Education/Training Program4.7%Licensed Practical Nurse - 4%Licensed Practical Nurse4%Addiction (Substance Use Disorder) Counselor - 3.5%Addiction (Substance Use Disorder) Counselor3.5%Registered Nurse - 3.4%Registered Nurse3.4%Pharmacist - 3.4%Pharmacist3.4%Addiction (Substance Use Disorder) Registered Nurse - 0.1%Addiction (Substance Use Disorder) Registered Nurse0.1%
Largest specialties in Ohio (% of in-state providers)

Board certification

Not published by CMS

CMS does not publish a per-provider board-certification field in NPPES. PlainDoctor does not have a reliable per-specialty certification rate to show for Addiction (Substance Use Disorder) Registered Nurse. Verify directly:

How MIPS and board certification work

The Merit-based Incentive Payment System (MIPS) scores providers 0–100 across four performance categories: Quality, Cost, Promoting Interoperability, and Improvement Activities, weighted under 42 CFR §414.1380. Reporting is voluntary for many small practices, so absence of a MIPS score is not a quality signal.

Board certification through an ABMS or AOA member board signals voluntary post-licensure examination plus continuous Maintenance of Certification cycles. Verify any individual provider's status through certificationmatters.org (ABMS) or osteopathic.org (AOA).

Akwasi Agyemang appears in the CMS NPPES registry as a Addiction (Substance Use Disorder) Registered Nurse provider at 1301 N HIGH ST, Columbus, OH, 43201, with a listed phone of (614) 299-6600. NPI 1407203482 was issued on 05/19/2016.

Medicare Part D records for calendar year 2023 show 1,269 prescription claims written by this provider, covering 75 Medicare beneficiaries and totaling roughly $87K in drug spend, split 12% brand-name and 87% generic by claim count.

Addiction (Substance Use Disorder) Registered Nurse is a narrow specialty nationwide, with 2,788 enrolled providers across 52 states and an average of 955 Part D claims per prescriber, so the context for interpreting these metrics differs meaningfully from a primary-care baseline.

Important: PlainDoctor is a directory of publicly available government data, not medical advice, a malpractice database, or a quality rating. Inclusion here does not imply a recommendation, and absence of complaints or sanctions on this page does not mean none exist, always verify credentials through the NPPES NPI Registry, your state medical board, and the ABMS or AOA before making healthcare decisions.

Practice Address

1301 N HIGH ST
Columbus, OH 43201

Provider Details

NPI 1407203482
Specialty Addiction (Substance Use Disorder) Registered Nurse
Gender Male
NPI Issued 05/19/2016

Industry payments received (2024) - CMS Open Payments transparency data

The federal Physician Payments Sunshine Act (part of the Affordable Care Act) requires drug and medical-device manufacturers + group purchasing organizations to publicly report payments and other transfers of value to physicians and teaching hospitals. The data below covers 2024 for Akwasi Agyemang. Source: openpaymentsdata.cms.gov.

Total received

$111

Largest payer

Otsuka America Pharmaceutical, Inc.

Most common payment type

Food and Beverage

Industry payments are not necessarily indicators of bias, they include research funding, consulting fees for evidence-based work, royalties for inventions, food at conferences, and similar items. The disclosure exists for transparency. Read our methodology for how we interpret this data.

License & disciplinary context - Ohio OMB 2023 annual report

Aggregate state board data only, NOT a determination of any individual provider's status. The figures below describe statewide disciplinary activity across all ~48K Ohio medical licensees in 2023 - they are NOT specific to Akwasi Agyemang. To verify Akwasi Agyemang's current license status, search the OMB public license lookup directly, or check the Federation of State Medical Boards (FSMB) verification service.

158
Total board actions, Ohio 2023
Across 154 cases
3.29
Actions per 1,000 licensees
Ohio statewide rate
probation
Most common action type
56 cases

OMB publishes annual disciplinary statistics as part of public-record reporting under each state's Administrative Procedure Act. See the full breakdown by action type and year on the Ohio disciplinary trends page. Cross-checked against FSMB U.S. Medical Regulatory Trends.

Brand vs generic prescribing mix · Typical

Akwasi Agyemang - brand share 12.0%
Addiction (Substance Use Disorder) Registered Nurse average

12% brand-name claims vs 87% generic, on 1,269 2023 Medicare Part D claims.

The federal Medicare Part D Generic Dispensing Rate national benchmark sits near 90% generic / 10% brand for primary-care prescribers, per CMS Office of the Actuary 2024 estimates. Higher brand share is common in specialty prescribing where generic equivalents are not available.

Medicare Part D Prescribing Data

CMS Medicare Part D prescriber-level data for calendar year 2023.

1,269
Total Claims
$87K
Total Drug Cost
75
Medicare Beneficiaries

Prescribing Breakdown

30-Day Fills
1,484
Total Day Supply
38,153
Brand vs Generic
12% brand / 87% generic
Brand Drug Cost
$63K
Generic Drug Cost
$23K
Antibiotic Claims
40

Patient Demographics

Average Patient Age
57.6 years
Avg HCC Risk Score
1.40
Gender Split
49% female / 51% male
Age Distribution
<65: 45, 65-74: 23, 75-84: N/A, 85+: N/A

Top Prescribed Drugs (Medicare Part D)

Top drugs by claim count for calendar year 2023. Based on Medicare Part D data only.

What Akwasi Agyemang prescribes most

Top Medicare Part D drugs by claim count, 2023

claims
Source CMS Medicare Part D Prescriber Public Use File As of 2023
Drug Claims
Buprenorphine-Naloxone
Buprenorphine Hcl/Naloxone Hcl
175
Gabapentin
77
Amlodipine Besylate
48
Albuterol Sulfate Hfa
Albuterol Sulfate
42
Trazodone Hcl
40
Atorvastatin Calcium
39
Omeprazole
37
Ibuprofen
31
Buspirone Hcl
29
Fluticasone Propionate
28

* Counts below 11 are suppressed by CMS for patient privacy. Generic names shown where available from CMS Part D data.

Addiction (Substance Use Disorder) Registered Nurse Overview

How Akwasi Agyemang fits within the Addiction (Substance Use Disorder) Registered Nurse landscape nationally.

2,788
Addiction (Substance Use Disorder) Registered Nurse Providers in US
52
States with Addiction (Substance Use Disorder) Registered Nurse
955
Avg Claims per Provider

Akwasi Agyemang's 1,269 claims are above the specialty average of 955.

Nearby Addiction (Substance Use Disorder) Registered Nurse Providers in Ohio

Other clinicians with the same primary specialty enrolled in Ohio, drawn from the same CMS NPPES roster as Agyemang.

Compare Addiction (Substance Use Disorder) Registered Nurse nationally: see state-by-state distribution →

Before you book an appointment

Use this federal record as your verification checklist, not as a recommendation.

  • Confirm the NPI record is current in the official CMS registry, providers update their own NPPES details, and moves can lag. Verify this NPI
  • Check the active license and any disciplinary history with the Ohio medical board, federal registration is not a license check. Credential verification guide
  • Weigh a second option: compare this provider with a nearby Addiction (Substance Use Disorder) Registered Nurse peer on Medicare volume and prescribing patterns. Compare providers

Medicare Part D and MIPS figures describe practice patterns in federal programs only, they are not quality ratings, and PlainDoctor does not rate, rank, or recommend providers.

Frequently Asked Questions

What is Akwasi Agyemang's specialty?
Akwasi Agyemang specializes in Addiction (Substance Use Disorder) Registered Nurse and practices in Columbus, Ohio.
How much does Akwasi Agyemang prescribe under Medicare Part D?
In 2023, Akwasi Agyemang wrote 1,269 Medicare Part D claims totaling $87K in drug costs for 75 beneficiaries.
Where is Akwasi Agyemang located?
Akwasi Agyemang is located at 1301 N HIGH ST, Columbus, OH, 43201. Phone: (614) 299-6600.
What is Akwasi Agyemang's NPI number?
Akwasi Agyemang's National Provider Identifier (NPI) is 1407203482, issued on 05/19/2016.
Does Akwasi Agyemang prescribe more brand-name or generic drugs?
Akwasi Agyemang's prescribing is 12% brand-name and 87% generic drugs by claim count, with $63K in brand drug costs.
How many Addiction (Substance Use Disorder) Registered Nurse providers are there in the US?
There are 2,788 Addiction (Substance Use Disorder) Registered Nurse providers across 52 states in the US. The average Addiction (Substance Use Disorder) Registered Nurse provider writes 955 Medicare Part D claims per year.
What drugs does Akwasi Agyemang prescribe most often?
Based on 2023 Medicare Part D data, Akwasi Agyemang's most frequently prescribed drugs include Buprenorphine-Naloxone, Gabapentin, Amlodipine Besylate. This reflects Medicare Part D prescriptions only and does not include commercial insurance or other payer types.
Does Akwasi Agyemang accept Medicare?
Akwasi Agyemang appears in CMS Medicare data with 1,269 Part D claims and 75 Medicare beneficiaries in 2023. Contact the provider's office directly to confirm current Medicare enrollment and accepted plans.
How can I verify Akwasi Agyemang's credentials?
Akwasi Agyemang's NPI is 1407203482. You can verify this through the NPPES NPI Registry, check state medical board records, and confirm board certification through the ABMS or AOA.

Data Sources

View source datasets and methodology notes
Provider Directory
CMS National Plan and Provider Enumeration System (NPPES), download.cms.gov/nppes, updated monthly. Contains NPI, specialty, credentials, and practice location.
Specialty Classification
NUCC Health Care Provider Taxonomy (nucc.org), the industry standard for classifying provider specialties in Medicare and Medicaid billing.
Prescribing Data
CMS Medicare Part D Prescriber Public Use File (2023). Includes claims, drug costs, beneficiaries, and opioid prescribing rates.
Limitations
Provider data is self-reported to CMS. Prescribing data reflects Medicare Part D only and does not include commercial insurance, Medicaid, or cash prescriptions. Claims below 11 beneficiaries are suppressed by CMS for privacy.

See our complete data methodology for details on how we collect and process government data.

Data as of April 2026 (NPPES) / 2023 (Medicare Part D). Source: Centers for Medicare & Medicaid Services (CMS).

Disclaimer: Data from CMS NPPES and Medicare Part D. PlainDoctor does not rate or rank providers. Provider information is self-reported and may not be current. Always verify information directly with the provider. About · Methodology

Compiled from official public sources by the PlainDoctor editorial team.

Every figure on PlainDoctor is rendered directly from the federal CMS NPPES registry, Medicare Part D, MIPS, and Open Payments records, no number is typed in by an editor. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error. Data current as of May 2026.